Feed GBLP
GB

Global Pharmatech, Inc. GBLP · OTC

$0.08 +0.00% (+$0.00)

Summary

17 / 100 · Bulios Score

What speaks for it

  • It earns 170 USD a year on every 100 USD of invested capital.
  • It holds more cash than debt: $106.1K against $90.6K.

What to watch

  • The company made a loss over the last 12 months.
  • Earnings per share swing sharply from year to year.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

Revenue (USD)

Diluted EPS (USD)

There is not enough revenue history yet to say how fast it grows.

Growth in detail

Does it make money?

Income figures for the last 12 months are not available.

Profitability in detail

Is it financially healthy?

Yes

It holds more cash than debt. The debt score is low because of the debt-to-equity ratio.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

This revenue breakdown is on the way.

By region

This revenue breakdown is on the way.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.